BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11242843)

  • 1. Breast cancer and hot flashes. Options for relief.
    Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
    [No Abstract]   [Full Text] [Related]  

  • 2. Venlafaxine hydrochloride for the treatment of hot flashes.
    Schober CE; Ansani NT
    Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.
    J Support Oncol; 2005; 3(4):312. PubMed ID: 16092603
    [No Abstract]   [Full Text] [Related]  

  • 4. Venlafaxine for hot flushes.
    Barlow DH
    Lancet; 2000 Dec; 356(9247):2025-6. PubMed ID: 11145483
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
    Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
    Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
    Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond estrogen: new alternatives for the management of hot flashes.
    Dvorak SR
    S D J Med; 2002 Jan; 55(1):11-2. PubMed ID: 11808405
    [No Abstract]   [Full Text] [Related]  

  • 8. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
    Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
    Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hot flashes in breast cancer survivors and men with prostate cancer.
    Stearns V
    Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for hot flushes in women receiving tamoxifen.
    Bydder SA; Spry NA
    Med J Aust; 2002 Sep; 177(5):266. PubMed ID: 12197825
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhormonal agents show promise against hot flashes.
    Gottlieb N
    J Natl Cancer Inst; 2000 Jul; 92(14):1118-20. PubMed ID: 10904081
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
    Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
    J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flushing in a menopausal woman taking venlafaxine.
    Grady-Weliky TA; Hartmann DM
    Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
    [No Abstract]   [Full Text] [Related]  

  • 15. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
    Buijs C; Mom CH; Willemse PH; Marike Boezen H; Maurer JM; Wymenga AN; de Jong RS; Nieboer P; de Vries EG; Mourits MJ
    Breast Cancer Res Treat; 2009 Jun; 115(3):573-80. PubMed ID: 18670875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.
    Weitzner MA; Moncello J; Jacobsen PB; Minton S
    J Pain Symptom Manage; 2002 Apr; 23(4):337-45. PubMed ID: 11997203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine and paroxetine in treatment-resistant depression.
    Gregson J
    Br J Psychiatry; 1999 Dec; 175():591. PubMed ID: 10789369
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
    Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
    J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
    Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
    J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concern about the use of venlafaxine to treat vasomotor symptoms.
    Zhou SS; Lun YZ; Li D
    JAMA Intern Med; 2015 Apr; 175(4):657-8. PubMed ID: 25844750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.